KHC
IDXX icon

Koesten Hirschmann & Crabtree’s Idexx Laboratories IDXX Stock Holding History

Koesten Hirschmann & Crabtree’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-25
Closed -$16K – 129
2025
Q3 		$16K Hold
25
– – 0.01% 123
2025
Q2 		$13.4K Hold
25
– – 0.01% 131
2025
Q1 		$10.5K Buy
+25
New +$10.9K 0.01% 129
2023
Q2 		– Sell
-2
Closed -$1K – 207
2023
Q1 		$1K Buy
+2
New +$957 ﹤0.01% 190

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSC
J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Koesten Hirschmann & Crabtree's IDXX Position: Q4 2025 in Review

Koesten Hirschmann & Crabtree sold out of Idexx Laboratories (IDXX) in Q4 2025, closing a stake of 25 shares — an estimated $16K sold.

Koesten Hirschmann & Crabtree first reported a position in IDXX in Q1 2023 and held it in 4 quarters. The position peaked at $16K in Q3 2025. 1,386 funds tracked by Wall St. Rank hold IDXX as of Q4 2025.

  • Koesten Hirschmann & Crabtree reported no remaining Idexx Laboratories position as of Q4 2025 after selling out during the quarter.
  • Koesten Hirschmann & Crabtree sold 25 Idexx Laboratories shares in Q4 2025, an estimated $16K.
  • Koesten Hirschmann & Crabtree first reported a position in Idexx Laboratories in Q1 2023 and held it in 4 quarters.
  • Koesten Hirschmann & Crabtree's Idexx Laboratories position peaked at $16K in Q3 2025.
  • 1,386 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2025.

Based on Koesten Hirschmann & Crabtree's 13F filing for Q4 2025, filed 9 Feb 2026.